Bone regeneration using a naturally grown HA/TCP carrier loaded with rhBMP-2 is independent of barrier-membrane effects

Journal of Biomedical Materials Research - Part A

Volumn 85, Issue 4, 2008, Pages 954-963

  Schopper, C ^a   Moser, D ^a   Spassova, E ^b   Goriwoda, W ^a   Lagogiannis, G ^a   Hoering, B ^c   Ewers, R ^a   Redl, H ^c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AlgOss Biotechnologies GmbH   (Austria)

^c LUDWIG BOLTZMANN INSTITUTE FOR EXPERIMENTAL AND CLINICAL TRAUMATOLOGY   (Austria)

Author keywords

BMP; Bone regeneration; Hydroxyapatite composite; Membrane; Scaffold

Indexed keywords

BIOMATERIALS; HYDROXYAPATITE; MATHEMATICAL MODELS; POROSITY;

BARRIER-MEMBRANE EFFECTS; BONE REGENERATION; HYDROXYAPATITE COMPOSITES;

BONE;

CALCIUM PHOSPHATE; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE REGENERATION; CALVARIA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; HISTOPATHOLOGY; MATERIALS TESTING; MEMBRANE; NONHUMAN; RABBIT;

ANIMALS; BIOCOMPATIBLE MATERIALS; BONE MORPHOGENETIC PROTEINS; BONE REGENERATION; CALCIUM PHOSPHATES; DURAPATITE; HUMANS; IMPLANTS, EXPERIMENTAL; MEMBRANES, ARTIFICIAL; MICROSCOPY, ELECTRON, SCANNING; RABBITS; RECOMBINANT PROTEINS; SKULL; TISSUE SCAFFOLDS; TRANSFORMING GROWTH FACTOR BETA;

EID: 44149108689     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.31525     Document Type: Article

References (41)

1. Schopper C, Ziya-Ghazvini F, Goriwoda W, Moser D, Wanschitz F, Spassova E, Lagogiannis G, Auterith A, Ewers R. HA/TCP compounding of a porous CaP biomaterial improves bone formation and scaffold degradation - A long term histological study. J Biomed Mater Res B Appl Biomater 2005;74:458-467.
2. Linde A, Albertus P, Dahlin C, Bjurstarn C, Sundin Y. Osteo-promotion: A soft tissue exclusion principle using a membrane for bone healing and bone neogenesis. J Periodontal 1993;64:1116-1128.
3. Urist MR. Bone: Formation by autoinduction. Science 1965;150:839-899.
4. Elima K. Osteoinductive proteins. Ann Med 1993;25:395-402.
5. Hoffmann A, Weich HA, Gross G, Hillmann G. Perspectives in the biological function, the technical and therapeutic application of bone morphogenetic proteins. Appl Microbiol Biotechnol 2001;57:294-308.
6. Vukicevic S, Stavljenic A, Pecina M. Discovery and clinical applications of bone morphogenetic proteins. Eur J Clin Chem Clin Biochem 1995;33:661-671.
7. Wozney JM. The bone morphogenetic protein family and osteogenesis. Mol Reprod Dev 1992;32:160-167.
8. Wozney JM. Bone morphogenetic proteins. Prog Growth Factor Res 1989;1:267-280.
9. Wozney JM. The bone morphogenetic protein family: Multifunctional cellular regulators in the embryo and adult. Eur J Oral Sci 1998;106(Suppl 1):160-166.
10. Hogan BLM. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 1996;10:1580-1594.
11. Lyons KM, Jones CM, Hogan BLM. The DVR gene family in embryonic development. Trends Genet 1991;7:408-412.
12. Rengachary SS. Bone morphogenetic proteins: Basic concepts. Neurosurg Focus 2002;13:1-6.
13. Jansen JA, Vehof JWM, Ruhe PQ, Kroeze-Deutman H, Kuboki Y, Takita H, Hedberg EL, Mikos AG. Growth factor-loaded scaffolds for bone engineering. J Control Release 2005;101:127-136.
14. Namikawa T, Terai H, Suzuki E, Hoshino M, Toyoda H, Nakamura H, Miyamoto S, Takahashi N, Ninomiya T, Takaoka K. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 delivered by a synthetic polymer and β-tricalcium phosphate in a rabbit model. Spine 2005;30:1717-1722.
15. Kaito T, Myoui A, Takaoka K, Saito N, Nishikawa M, Tamai N, Ohgushi H, Yoshikawa H. Potentiation of the activity of bone morphogenetic protein-2 in bone regeneration by a PLA-PEG/hydroxyapatite composite. Biomaterials 2005;26:73-79.
16. Laffargue PH, Hildebrand HF, Rtaimate M, Frayssinet P, Amoureux JP, Marchandise X. Evaluation of human recombinant bone morphogenetic protein-2-loaded tricalcium phosphate implants in rabbits' bone defects. Bone 1999;25:55S-58S.
17. Ono I, Tateshita T, Kuboki Y. Prostaglandin E1 and recombinant bone morphogenetic protein effect on strength of hydroxyapatite implants. J Biomed Mater Res 1999;45:337-344.
18. Donath K, Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissue. The sage-schliff (sawing and grinding) technique. J Oral Pathol 1982;11:198-326.
19. Schopper C, Moser D, Sabbas A, Lagogiannis G, Spassova E, König F, Donath K, Ewers R. The fluorohydroxyapatite (FHA) FRIOS Algipore is a suitable biomaterial for the reconstruction of severely atrophic human maxillae. Clin Oral Implants Res 2003;14:743-749.
20. Takeishi H, Irie K, Okuda K, Ozawa H, Yajima T, Ejiri S. Molded bone augmentation by a combination of barrier membrane and recombinant human bone morphogenetic protein-2. Oral Dis 2001;7:281-286.
21. Kingsley DM. What do BMPs do in mammals? Clues from the mouse short-ear mutation. Trends Genet 1994;10:16-21.
22. Yasko AW, Lane JM, Fellinger EJ, Rosen V, Wozney JM, Wang EA. The healing of segmental bone defects, induced by recombinant human bone morphogenetic protein (rhBMP-2). A radiographic, histological, and biomechanical study in rats. J Bone Joint Surg Am 1992;74:659-670.
23. Hay E, Lemonnier J, Fromigue O, Guenou H, Marie PJ. Bone morphogenetic protein receptor IB signaling mediates apoptosis independently of differentiation in osteoblastic cells. J Biol Chem 2004;279:1650-1658.
24. Kenley R, Marden L, Turek T, Jin L, Ron E, Hollinger JO. Osseous regeneration in the rat calvarium using novel delivery systems for recombinant human bone morphogenetic protein-2 (rhBMP-2). J Biomed Mater Res 1994;28:1139-1147.
25. Reddi AH. Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat Biotechnol 1998;16:247-252.
26. Aspenberg P, Lohmander S, Thorngren KG. Monkey bone matrix induces bone formation in the athymic rats, but not in adult monkeys. J Orthop Res 1991;9:20-25.
27. Miyamoto S, Takaoka K, Ono K. Bone induction in monkeys by bone morphogenetic protein. A trans-filter technique. J Bone Joint Surg Br 1993;75:107-110.
28. Govender S, Csimma C, Genant HK, Valentin-Opran A, Amit Y, Arbel R, Aro H, Atar D, Bishay M, Borner MG, Chiron P, Choong P, Cinats J, Courtenay B, Feibel R, Geulette B, Gravel C, Haas N, Raschke M, Hammacher E, van der Velde D, Hardy P, Holt M, Josten C, Ketterl RL, Lindeque B, Lob G, Mathevon H, McCoy G, Marsh D, Miller R, Munting E, Oevre S, Nordsletten L, Patel A, Pohl A, Rennie W, Reynders P, Rommens PM, Rondia J, Rossouw WC, Daneel PJ, Ruff S, Ruter A, Santavirta S, Schildhauer TA, Gekle C, Schneider R, Segal D, Seiler H, Snowdowne RB, Stapert J, Taglang G, Verdonk R, Vogels L, Weckbach A, Wentzensen A, Wisniewski T. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84:2123-2134.
29. Seeherman H, Wozney J, Li R. Bone morphogenetic protein delivery systems. Spine 2002;27(Suppl 1):16-23.
30. Pecora G, Baek SH, Rethnam S, Kim S. Barrier membrane techniques in endodontic microsurgery. Dent Clin North Am 1997;41:585-602.
31. Steenberghe D, Johansson C, Quirynen M, Molly L, Albrektsson T, Naert I. Bone augmentation by means of a stiff occlusive titanium barrier. A study in rabbits and humans. Clin Oral Implants Res 2003;14:63-71.
32. Buser D, Broggini N, Wieland M, Schenk RK, Denzer AJ, Cochran DL, Hoffmann B, Lussi A, Steinemann SG. Enhanced bone apposition to a chemically modified SLA titanium surface. J Dent Res 2004;83:529-533.
33. Buser D. Titanium for dental applications. II. Implants with roughened surfaces. In: Brunette DM, Tengvall P, Textor M, Thomson P, editors. Titanium in Medicine. Berlin: Springer; 2001. p 876-888.
34. Cochran DL, Schenk RK, Lussi A, Higginbottom FL, Buser D. Bone response to unloaded and loaded titanium implants with a sandblasted and acid-etched surface. A histometric study in the canine mandible. J Biomed Mater Res 1998;40:1-11.
35. Hardwick R, Hayes BK, Flynn C. Devices for dentoalveolar regeneration: An up-to-date literature review. J Periodontal 1995;66:495-505.
36. Scantlebury TV. A decade of technology development for guided tissue regeneration. J Periodontol 1993;64(Suppl):1129-1137.
37. Schmid J, Hammerle CHF, Olah AJ, Lang NP. Membrane permeability is unnecessary for guided generation of new bone: An experimental study in the rabbit. Clin Oral Implants Res 1994;5:125-130.
38. Kostopoulos L, Karring T, Uraguchi R. Formation of jawbone tuberosities by guided tissue regeneration. An experimental study in the rat. Clin Oral Implants Res 1994;5:245-253.
39. Zellin G, Lindhe J. Effect of different membrane porosities on experimental bone neogenesis in rats. Biomaterials 1996;17:695-702.
40. Warnke PH, Wiltfang J, Springer I, Acil Y, Bolte H, Kosmahl M, Russo PA, Sherry E, Lutzen U, Wolfart S, Terheyden H. Man as living bioreactor: Fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials 2006;27:3163-3167.
41. Warnke PH, Springer IN, Wiltfang J, Acil Y, Eufinger H, Wehmoller M, Russo PA, Bolte H, Sherry E, Behrens E, Terheyden H. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004;364:766-770.